Answers are grounded in this paper and cite their sources.
The authors report a significant increase in dyscontrol in patients with borderline personality disorder who were taking alprazolam during a double-blind, placebo-controlled crossover study. They suggest that caution be used in prescribing alprazolam to patients with similar histories.
No takes yet. Share an insight, caveat, or question.
Gardner et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: